Overview

Domperidone for Chronic Nausea and Vomiting

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide oral domperidone to patients with gastroparesis, between the ages of 18 and 60 years of age, who have failed standard treatment. Standard therapy at the University of Iowa is eating blended foods, liquid diet, Eryped syrup (125 mg TID) 30 minutes before meals, or reglan (20 mg BID).
Details
Lead Sponsor:
Assouline-Dayan, Yehudith
Yehudith Assouline-Dayan
Treatments:
Domperidone